Figures & data
![](/cms/asset/f58a55be-ec5c-436f-bb77-ec807f33ea6e/ianb_a_1470527_uf0001_c.jpg)
Table 1. Zeta potential values of multifunctional dendrimer conjugates (mean ± SD, n = 3).
Figure 3. Percentage of hemolysis obtained from the interaction of the G4 conjugates with RBC suspension. Data is represented as mean ± SD, n = 3. Statistical significance was determined for G4 PEG and G4 PEG R8 against plain G4 dendrimer.
![Figure 3. Percentage of hemolysis obtained from the interaction of the G4 conjugates with RBC suspension. Data is represented as mean ± SD, n = 3. Statistical significance was determined for G4 PEG and G4 PEG R8 against plain G4 dendrimer.](/cms/asset/54af11f1-f0d6-4173-9707-1812f6587aef/ianb_a_1470527_f0003_c.jpg)
Figure 4. (A) Confocal microscopy images of HeLa cells after 1 and 4 h of incubation with F-G4-PEG and F-G4-PEG-R8. (B) Cellular uptake of fluorescently tagged G4 conjugates with and without R8 modification in HeLa cells after 1 and 4 h incubation as assessed by flow cytometer (mean ± SD, n = 3).
![Figure 4. (A) Confocal microscopy images of HeLa cells after 1 and 4 h of incubation with F-G4-PEG and F-G4-PEG-R8. (B) Cellular uptake of fluorescently tagged G4 conjugates with and without R8 modification in HeLa cells after 1 and 4 h incubation as assessed by flow cytometer (mean ± SD, n = 3).](/cms/asset/2f173354-38f2-49b7-8d42-96de1b764f45/ianb_a_1470527_f0004_c.jpg)
Figure 5. Percentage cell viability of HeLa cells treated with different concentrations of PTX, G4-PTX-PEG and G4-PTX-PEG-R8 at 24 and 48 h (mean ± SD; n = 3).
![Figure 5. Percentage cell viability of HeLa cells treated with different concentrations of PTX, G4-PTX-PEG and G4-PTX-PEG-R8 at 24 and 48 h (mean ± SD; n = 3).](/cms/asset/6186862e-a3fe-4af4-87de-9bc3e663d462/ianb_a_1470527_f0005_c.jpg)
Figure 6. Quantitative estimation of apoptosis induced by various PTX treatments as studied by AnnexinV FITC/PI staining assay. Q1: live cells; Q2: early apoptotic; Q3: late apoptotic; Q4: necrotic cells.
![Figure 6. Quantitative estimation of apoptosis induced by various PTX treatments as studied by AnnexinV FITC/PI staining assay. Q1: live cells; Q2: early apoptotic; Q3: late apoptotic; Q4: necrotic cells.](/cms/asset/a0aafda0-d952-4fee-ac59-6742316c7d87/ianb_a_1470527_f0006_c.jpg)
Figure 7. (A) Penetration of G4 conjugates in 3D cultured spheroids at various depths after 1 and 4 h incubation captured as Z-stacks by confocal microscopy. (B) Quantitative assessment of cellular uptake in 3D spheroids treated with F-G4-PEG and F-G4-PEG-R8 by flow cytometry (mean ± SD; n = 3).
![Figure 7. (A) Penetration of G4 conjugates in 3D cultured spheroids at various depths after 1 and 4 h incubation captured as Z-stacks by confocal microscopy. (B) Quantitative assessment of cellular uptake in 3D spheroids treated with F-G4-PEG and F-G4-PEG-R8 by flow cytometry (mean ± SD; n = 3).](/cms/asset/39721e6d-8259-4ffa-bcd8-f929991adfcc/ianb_a_1470527_f0007_c.jpg)
Figure 8. (A) Photomicrograph of spheroids after different PTX treatments captured at Day 0, Day 3 and Day 6 using bright field microscope at 10× magnification. (B) Graphical representation of spheroid growth inhibition (mean of diameter in µm ± SD; n = 3).
![Figure 8. (A) Photomicrograph of spheroids after different PTX treatments captured at Day 0, Day 3 and Day 6 using bright field microscope at 10× magnification. (B) Graphical representation of spheroid growth inhibition (mean of diameter in µm ± SD; n = 3).](/cms/asset/a981f24f-0014-4df1-b0e5-cfbe4f4f36f0/ianb_a_1470527_f0008_c.jpg)